Enterprise Singapore
Navigating the landscape of novel gene therapies: How small countries can unlock the global gene therapy market
The future of #biotech investments hinges on the continued evolution of gene therapies and the integration of novel technologies into biological research standards ... In this dynamic landscape, small countries such as #Singapore and #Estonia might achieve catalyzing potential by providing relevant, consistent, and innovation-driven regulatory frameworks to…
Enterprise Singapore and Latin Leap launch first market entry program to help Singapore tech startups expand and grow in Latin American market
Latin Leap and Enterprise Singapore (ESG) have launched the first market entry programme to help tech startups in Singapore to have greater access to business and partnership opportunities in Latin America. The Leap2LatAm programme aims to connect tech startups in Singapore with potential customers, multipliers, and joint venture partners in Latin America…
